Digoxin Loading Dose for Acute Decompensated Heart Failure with Reduced Ejection Fraction
For patients with acute decompensated heart failure with reduced ejection fraction (HFrEF), the recommended loading dose of digoxin is 0.5 to 0.75 mg initially, followed by additional doses of 0.125 to 0.375 mg at 6 to 8-hour intervals until clinical effect is achieved, with a total loading dose typically between 0.75 to 1.25 mg for a 70 kg patient. 1
Loading Dose Administration Protocol
Initial Dosing Strategy
- Begin with an initial dose of 0.5 to 0.75 mg of digoxin tablets 1
- This initial dose typically produces a detectable effect in 0.5 to 2 hours
- Maximum effect is usually observed within 2 to 6 hours after administration
Subsequent Dosing
- Additional fractions of 0.125 to 0.375 mg may be given at 6 to 8-hour intervals 1
- Carefully assess clinical response before each additional dose
- Continue until clinical evidence of adequate effect is noted (improved heart rate control, hemodynamics)
Total Loading Dose
- For a typical 70 kg patient with normal renal function, the total loading dose required to achieve therapeutic peak body stores (8-12 mcg/kg) is approximately 0.75 to 1.25 mg 1
- The loading dose should be administered in divided portions, with roughly half the total given as the first dose 1
Factors Affecting Dosing Decisions
Patient-Specific Considerations
- Age: Lower doses for patients >70 years (0.125 mg daily or every other day) 2, 3
- Renal function: Reduce dose in patients with impaired renal function 1
- Body weight: Base calculations on lean body weight 1
- Concomitant medications: Adjust dose if patient is taking medications that affect digoxin levels (amiodarone, verapamil, diltiazem, certain antibiotics, quinidine) 4, 3
Monitoring Parameters
- Target serum digoxin concentration: 0.5-1.0 ng/mL 3
- Levels above 2.0 ng/mL are associated with toxicity 2
- Monitor serum electrolytes (particularly potassium, magnesium, and calcium) 3
- Assess renal function regularly 3
Special Considerations for ADHF
- Digoxin is not indicated as primary treatment for stabilization of acutely decompensated heart failure 5
- However, it may be considered in decompensated HF patients prior to initiation of a beta-blocker 4
- For patients with atrial fibrillation and HFrEF, digoxin can be particularly useful for initial control of ventricular rate 4
Potential Adverse Effects to Monitor
- Cardiac arrhythmias (sinoatrial and AV block, atrial and ventricular arrhythmias) 4
- Gastrointestinal symptoms (nausea, anorexia) 2
- Neurological complaints (visual disturbances, confusion) 4
- Risk of toxicity increases with hypokalemia, hypomagnesemia, or hypothyroidism 2
Contraindications
- Second or third-degree heart block (without a permanent pacemaker) 4
- Pre-excitation syndromes 4
- Previous evidence of digoxin intolerance 4
- Use cautiously in patients with suspected sick sinus syndrome 4
Remember that after the loading dose, maintenance therapy should be initiated based on the patient's renal function and other clinical factors, typically ranging from 0.125 to 0.25 mg daily for most adult patients with HFrEF 2.